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• Asthma affects over 24 million individuals in the US
• Prevalence of the condition is increasing in the US and worldwide
• Classified into 4 severities:
• Intermittent
• Mild Persistent
• Moderate Persistent
• Severe Persistent
• Since most patients are already on long-term asthma medication, prescribed 
medications were used as a proxy for asthma severity according to NIH guidelines for 
care
• Study Population: All patients ages 5-18 with asthma that were admitted to pulmonology 
or allergy departments at Nemours Children’s Hospital in Wilmington, DE between 
01Nov2014 – 01Nov2017 and were prescribed at least one asthma medication
Prescribed Medications
Step of Treatment
Asthma Severity
• Children with severe persistent asthma experience symptoms 
every day, are extremely limited, and account for a sizeable 
portion of healthcare costs
• The prevalence of severe asthma in children and adolescents 
is poorly understood
• We aimed to define the prevalence of asthma severities in 
an urban inpatient setting across different demographics
Ages 5-11 Ages 12-18
n Freq. % n Freq. %
Asthma Severity
Intermittent 70 10.97% 94 18.29%
Mild Persistent 121 18.97% 100 19.46%
Moderate Persistent 211 33.07% 135 26.26%
Severe Persistent 236 36.99% 185 35.99%
Asthma Severities of the Study Population
Age Group Χ² p
Age Groups N/A 15.208 0.002
Sex 5-11 6.276 0.099
12-18 1.715 0.634
Race 5-11 19.743 0.003
12-18 18.244 0.006
Ethnicity 5-11 1.279 0.734
12-18 1.040 0.792
Results of Chi-Square Tests
Results of Binary Logistic Regression
for moderate/severe compared to intermittent/mild 
Χ² p AOR 95% CI
Age Group
Ages 5-11 7.144 0.008 1.406 1.131 – 1.879
Ages 12-18 (Ref)
Sex
Male 1.328 0.249 0.863 0.671 – 1.109
Female (Ref)
Race
African American 14.893 <0.001 1.727 1.309 – 2.280
Other 1.162 0.281 1.279 0.818 – 2.000
White (Ref)
Ethnicity
Non-Hisp. or Latino 0.313 0.576 0.886 0.579 – 1.355
Hisp. or Latino (Ref)
• We found that most children and adolescents who are 
hospitalized for asthma are moderate/severe asthmatics
• Those ages 5-11 are more likely to be hospitalized for 
moderate/severe asthma compared to those ages 12-18
• African Americans are more likely to be hospitalized for 
moderate/severe asthma compared to Whites
• This information can be used to generate hypotheses for 
future studies can be used to better address patient needs
• Future research to reduce prevalence might focus on:
• Identification of more indicative risk factors
• Earlier screening methods
• New and more personalized therapies
• Only generalizable to clinical inpatient settings with 
similar demographic patient base
• Prescribing habits of clinicians may not reflect what 
is actually recommended (Flovent 110 mg/act caused 
many ages 5-11 to be high-dose ICS but not 12-18)
• Those who did not fall into defined step of treatment 
were assumed to be moderate persistent asthmatics
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